USPTO serial 78714613
COBALT LABORATORIES
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- KING, CHRISTINA B
- Law office
- DIVISIONAL UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with COBALT LABORATORIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sally M. Abel, Esq., Karen A. Webb, Esq.
Sally M. Abel, Esq., Karen A. Webb, Esq. FENWICK & WEST LLPSILICON VALLEY CENTER801 CALIFORNIA STREETMOUNTAIN VIEW, CA 94041-2008Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, preparations for the prevention and treatment of cancers; pharmaceutical preparations, namely, platelet stimulating factors; Pharmaceutical preparations for the treatment of urological disorders, gastrointestinal disorders, allergies, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, smoking cessation preparations, medicated tissue and skin repair preparations; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations comprising protein kinase or phosphatase for use in the treatment of cancer; pharmaceutical preparations affecting signal transduction pathways for use in the treatment of inflammatory diseases, autoimmune diseases, and psychiatric diseases; Pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas and sarcomas; Pharmaceutical preparations for the treatment of pains, fever, angina, otorhinolaryngology, gastric and liver illnesses, arterial and venous illnesses, rheumatic illnesses; analgesics, frostbite salve for pharmaceutical purposes, hemorrhoid treatment preparations, pharmaceutical preparations for the treatment of headaches, bath salts for medical purposes, medicated mouthwashes, herbal mud packs for therapeutic purposes, magnetic bracelets for medical purposes, tranquilizers, sedatives, tobacco free cigarettes for medical purposes, medicines for alleviating constipation, contraceptives chemical preparations, radiological contrast substances for medical purposes, namely, contrast media for in-vivo imaging, corn remedies, namely, corn creams, corn pads and corn plasters, cotton for medical purposes, diagnostic preparations for medical purposes, pharmaceutical preparations for the treatment of pain, fever, angina otorhinolaryngology, gastric and liver illnesses, arterial and venous illnesses, rheumatic illnesses, mineral water for medical purposes; Pharmaceutical preparations for the treatment of smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles; pharmaceutical preparations for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labor pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical preparations for the treatment of muscle dystonias, nerve disorders, spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy. Pharmaceutical preparations and substances, namely, anti-infective, anti-bacterials, antivirals, hemostatic agents, pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI), cerebral vasodilators; Prescription pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the peripheral nervous system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control, anesthetics for surgical and non-surgical use; pharmaceutical preparations for use in oncology for the prevention and treatment of disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 12, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 12, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 13, 2009 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Nov 13, 2009 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 20, 2009 | IROA | RESPONSE TO ITU OFFICE ACTION ENTERED | — |
| Oct 20, 2009 | FAXX | FAX RECEIVED | — |
| Sep 25, 2009 | INCD | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | — |
| Sep 23, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 11, 2009 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Sep 11, 2009 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 11, 2009 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Sep 11, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 11, 2009 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 11, 2009 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 11, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 11, 2008 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 11, 2008 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 11, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 31, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 11, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 11, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 11, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 31, 2007 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 12, 2007 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 16, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 27, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 30, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 30, 2006 | ALIE | ASSIGNED TO LIE | — |
| Nov 13, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 3, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 2, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 1, 2006 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Apr 1, 2006 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Mar 25, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 23, 2005 | NWAP | NEW APPLICATION ENTERED | — |